Ifp Advisors, Inc Biotechnology

Ifp Advisors, Inc

$3.28 Billion
Q2 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
AKRO Akero Therapeutics, Inc.	$2.51B	$8,000 0.0% of portfolio	157	Q2 2025 Added 4.67%
ARDX Ardelyx, Inc.	$878M	$7,000 0.0% of portfolio	1,812	Q2 2025 New
BCRX Biocryst Pharmaceuticals Inc	$1.28B	$6,000 0.0% of portfolio	728	Q2 2025 Added 1,273.58%
BPMC Blueprint Medicines Corp	$7.73B	$6,000 0.0% of portfolio	50	Q2 2025 New
ALDX Aldeyra Therapeutics, Inc.	$295M	$5,000 0.0% of portfolio	1,404	Q2 2025 New
GLUE Monte Rosa Therapeutics, Inc.	$564M	$5,000 0.0% of portfolio	1,182	Q2 2025 New
SANA Sana Biotechnology, Inc.	$869M	$5,000 0.0% of portfolio	1,901	Q2 2025 New
SAGE Sage Therapeutics, Inc.	$516M	$4,000 0.0% of portfolio	440	Q2 2025 New
ADMA Adma Biologics, Inc.	$3.04B	$3,000 0.0% of portfolio	216	Q2 2025 Added 113.86%
ARVN Arvinas, Inc.	$517M	$3,000 0.0% of portfolio	424	Q2 2025 New
KYMR Kymera Therapeutics, Inc.	$3.27B	$3,000 0.0% of portfolio	69	Q2 2025 New
LGND Ligand Pharmaceuticals Inc	$3.23B	$3,000 0.0% of portfolio	35	Q2 2025 Added 288.89%
ORIC Oric Pharmaceuticals, Inc.	$493M	$3,000 0.0% of portfolio	297	Q2 2025 Added 2,375.0%
ZLAB Zai Lab LTD	$2.53B	$3,000 0.0% of portfolio	94	Q2 2025 New
ARQT Arcutis Biotherapeutics, Inc.	$1.49B	$2,000 0.0% of portfolio	187	Q2 2025 Added 1,338.46%
CPRX Catalyst Pharmaceuticals, Inc.	$2.2B	$2,000 0.0% of portfolio	104	Q2 2025 Added 352.17%
ENTA Enanta Pharmaceuticals Inc	$224M	$2,000 0.0% of portfolio	385	Q2 2025 New
GMAB Genmab A/S	$18.9B	$2,000 0.0% of portfolio	100	Q2 2025 Reduced 16.67%
HUMA Humacyte, Inc.	$159M	$2,000 0.0% of portfolio	1,061	Q2 2025 Reduced 10.61%
ITOS I Teos Therapeutics, Inc.	$361M	$2,000 0.0% of portfolio	230	Q2 2025 Added 721.43%
LYRA Lyra Therapeutics, Inc.	$177M	$2,000 0.0% of portfolio	300	Q2 2025 New
MIRM Mirum Pharmaceuticals, Inc.	$2.6B	$2,000 0.0% of portfolio	42	Q2 2025 New
NUVL Nuvalent, Inc.	$4B	$2,000 0.0% of portfolio	34	Q2 2025 New
VIR Vir Biotechnology, Inc.	$696M	$2,000 0.0% of portfolio	509	Q2 2025 New
URGN Uro Gen Pharma Ltd.	$460M	$2,000 0.0% of portfolio	162	Q2 2025 New
ADPT Adaptive Biotechnologies Corp	$2.48B	$1,000 0.0% of portfolio	91	Q2 2025 Added 225.0%
ANIX Anixa Biosciences Inc	$120M	$1,000 0.0% of portfolio	500	Q1 2025 New
BBIO Bridge Bio Pharma, Inc.	$9.19B	$1,000 0.0% of portfolio	44	Q2 2025 Added 214.29%
CDXC Chroma Dex Corp.	$420M	$1,000 0.0% of portfolio	258	Q2 2025 New
IBRX Immunity Bio, Inc.	$905M	$1,000 0.0% of portfolio	439	Q2 2025 New
JANX Janux Therapeutics, Inc.	$1.14B	$1,000 0.0% of portfolio	56	Q2 2025 Added 5,500.0%
KRYS Krystal Biotech, Inc.	$5.08B	$1,000 0.0% of portfolio	10	Q2 2025 New
KURA Kura Oncology, Inc.	$654M	$1,000 0.0% of portfolio	239	Q2 2025 New
ORMP Oramed Pharmaceuticals Inc.	$90.1M	$1,000 0.0% of portfolio	500	Q1 2024 Reduced 66.67%
RGNX Regenxbio Inc.	$518M	$1,000 0.0% of portfolio	187	Q2 2025 Added 679.17%
RVPH Reviva Pharmaceuticals Holdings, Inc.	$11.2M	$1,000 0.0% of portfolio	4,000	Q2 2025 Reduced 18.37%
RCKT Rocket Pharmaceuticals, Inc.	$269M	$1,000 0.0% of portfolio	682	Q2 2025 Added 270.65%
TNGX Tango Therapeutics, Inc.	$693M	$1,000 0.0% of portfolio	233	Q2 2025 New
TARS Tarsus Pharmaceuticals, Inc.	$1.85B	$1,000 0.0% of portfolio	48	Q2 2025 Added 4,700.0%
VCEL Vericel Corp	$1.73B	$1,000 0.0% of portfolio	41	Q2 2025 Added 70.83%
YMAB Y M Abs Therapeutics, Inc.	$376M	$1,000 0.0% of portfolio	334	Q2 2025 New
AGIO Agios Pharmaceuticals, Inc.	$2.2B	$0 0.0% of portfolio	0	Q2 2025 New
AKBA Akebia Therapeutics, Inc.	$388M	$0 0.0% of portfolio	0	Q2 2025 New
ALEC Alector, Inc.	$119M	$0 0.0% of portfolio	9	Q2 2025 New
ALLO Allogene Therapeutics, Inc.	$170M	$0 0.0% of portfolio	31	Q2 2025 New
ALT Altimmune, Inc.	$194M	$0 0.0% of portfolio	200	Q2 2025 Reduced 0.5%
FOLD Amicus Therapeutics, Inc.	$2.49B	$0 0.0% of portfolio	165	Q2 2025 Reduced 98.59%
ANNX Annexon, Inc.	$149M	$0 0.0% of portfolio	108	Q2 2025 New
ANVS Annovis Bio, Inc.	$15.9M	$0 0.0% of portfolio	110	Q2 2025 New
ABUS Arbutus Biopharma Corp	$682M	$0 0.0% of portfolio	0	Q2 2025 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.